Evidence map›Paper›PMID 32564127›Full record

ArticleEuropean archives of psychiatry and clinical neuroscience2021

Serum zonulin and claudin-5 levels in patients with schizophrenia.

Ayşe Usta, Faruk Kılıç, Arif Demirdaş, Ümit Işık, Duygu Kumbul Doğuç, Mustafa Bozkurt

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of psychiatry and clinical neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. The role of tight junction proteins in the pathogenesis of schizophrenia.European archives of psychiatry and clinical neuroscience · 2026
    Review
  7. Article
  8. Article
  9. Review
  10. Serum Zonulin Levels in Patients with Heroin Addiction.Sisli Etfal Hastanesi tip bulteni · 2026
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Association of Plasma Claudin-5 with Age and Alzheimer Disease.International journal of molecular sciences · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ayşe UstaDepartment of Psychiatry, Süleyman Demirel University Medicine Faculty, 32260, Isparta, Turkey.
Faruk KılıçDepartment of Psychiatry, Süleyman Demirel University Medicine Faculty, 32260, Isparta, Turkey. drfarukk33@hotmail.com.ORCID http://orcid.org/0000-0002-2259-4028
Arif DemirdaşDepartment of Psychiatry, Süleyman Demirel University Medicine Faculty, 32260, Isparta, Turkey.
Ümit IşıkDepartment of Child and Adolescent Psychiatry, Süleyman Demirel University Medicine Faculty, Isparta, Turkey.
Duygu Kumbul DoğuçDepartment of Biochemistry, Süleyman Demirel University Medicine Faculty, Isparta, Turkey.
Mustafa BozkurtDepartment of Biochemistry, Süleyman Demirel University Medicine Faculty, Isparta, Turkey.
Süleyman Demirel University · TR

Funding

Süleyman Demirel Üniversitesi TTU-2019-6946
6 · The paper itself

Abstract

The aim of this research was to assess whether or not changes in the concentrations of serum zonulin and claudin-5 in patients with schizophrenia could have etiopathogenetic importance. In previous studies, the data regarding the relationship between intestinal and blood-brain barrier (BBB) permeability and the etiology of schizophrenia have been limited. In this study, we assumed that there may be a difference in serum zonulin and claudin-5 levels in patients with schizophrenia, which may affect the severity of the disease. Fifty schizophrenia patients and 50 healthy controls were included in this study. The patients were administered the Positive Symptoms Assessment Scale (SAPS) and Negative Symptoms Assessment Scale (SANS) to determine the severity of symptoms. Venous blood samples were collected, and the serum zonulin and claudin-5 levels were measured. The mean serum zonulin levels were significantly increased in patients with schizophrenia when compared to the control group. Serum claudin-5 levels were decreased in the schizophrenia patients when compared to the controls. The present study indicates that zonulin is increased and claudin-5 is decreased in patients with schizophrenia. These findings extend the existing knowledge on the dysregulation of intestinal permeability, especially zonulin, and BBB, especially claudin-5, and show that both proteins may be involved in the etiopathogenesis of schizophrenia.

Indexed as

SchizophreniaClaudin-5HaptoglobinsHumansPermeabilityProtein PrecursorsClaudin-5HaptoglobinsProtein PrecursorszonulinBlood–brain barrierClaudin-5Intestinal permeabilitySchizophreniaZonulin

Identifiers

PMID32564127
OpenAlexW3035965163

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.